Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme. (2019)
Attributed to:
MRC Centre for Neuropsychiatric Genetics and Genomics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/jnnp-2018-318360
PubMed Identifier: 30242090
Publication URI: http://europepmc.org/abstract/MED/30242090
Type: Journal Article/Review
Volume: 90
Parent Publication: Journal of neurology, neurosurgery, and psychiatry
Issue: 3
ISSN: 0022-3050